Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "Inc"

5645 News Found

Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant
Drug Approval | July 28, 2025

Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant

This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms


GSK forges $12 billion alliance with Hengrui Pharma
News | July 28, 2025

GSK forges $12 billion alliance with Hengrui Pharma

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology


Sigachi Industries reports Q1 FY26 consolidated loss at Rs. 100.35 Cr
News | July 27, 2025

Sigachi Industries reports Q1 FY26 consolidated loss at Rs. 100.35 Cr

Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025


Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
People | July 27, 2025

Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director

Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation


Laurus Labs to invest €5 million in JV KRKA Pharma
News | July 27, 2025

Laurus Labs to invest €5 million in JV KRKA Pharma

The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility


Laurus Labs consolidated Q1 FY2026 PAT at Rs. 163.02 Cr
News | July 26, 2025

Laurus Labs consolidated Q1 FY2026 PAT at Rs. 163.02 Cr

Laurus Labs has reported total income of Rs. 1,580 crores during the period ended June 30, 2025


Solara Active Pharma Sciences consolidated Q1FY26 PAT rises to Rs. 10.52 Cr
News | July 26, 2025

Solara Active Pharma Sciences consolidated Q1FY26 PAT rises to Rs. 10.52 Cr

Solara Active Pharma Sciences has reported total income of Rs. 320.13 crores during the period ended June 30, 2025


Cipla reports Q1 FY2025-26 consolidated profit up at Rs. 1,297.62 Cr
News | July 26, 2025

Cipla reports Q1 FY2025-26 consolidated profit up at Rs. 1,297.62 Cr

Cipla has reported total income of Rs. 7,216.03 crores during the period ended June 30, 2025


RPG Life Sciences Q1 FY2026 PAT slips to Rs. 26.29 Cr
News | July 26, 2025

RPG Life Sciences Q1 FY2026 PAT slips to Rs. 26.29 Cr

RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025